LEXINGTON, Mass. & SAN DIEGO--(BUSINESS WIRE)--Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) and Trius Therapeutics, Inc. (NASDAQ: TSRX) today announced that they have signed a definitive agreement ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback